Study shows two drugs are best for HIV infectionBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7009.827 (Published 30 September 1995) Cite this as: BMJ 1995;311:827
- LUISA DILLNER
People with HIV infection and AIDS who start treatment with two antiretroviral drugs had increased survival rates of over 40% during an average 26 month period of follow up, according to the interim results of an international multicentre trial released this week. The delta trial, started in 1992, was unblinded after the independent monitoring committee advised the trial's coordinators that the differences between the treatment groups--those taking combination therapy as opposed to those taking just zidovudine--were substantial and that the results should be made public.
“We have been criticised for not getting a paper together, but it will take about three months to collect all the data and another month to analyse it,” said Dr Tim Peto, a consultant physician at the John Radcliffe Hospital in Oxford and member …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial